Dr. Edisson 'Xavier' Vega-Cordova, MD

Dr. Vega-Cordova practices at South Florida ENT Associates, Inc. in Hialeah, Florida.

Dr. Vega-Cordova's NPI, 1750574190, was assigned on August 20, 2007. Dr. Vega-Cordova graduated from Universidad San Francisco de Quito in 2003. Dr. Vega-Cordova holds Florida license ME134284.

Dr. Vega-Cordova's primary practice is South Florida ENT Associates, Inc., at 7100 W 20th Ave Suite 608 Suite 608, Hialeah, FL 33016-1824. The practice phone is (305) 557-4016.

Dr. Vega-Cordova's primary practice is South Florida ENT Associates, Inc. in Hialeah, Florida. The medical group on file is South Florida ENT Associates.

Dmand AI tracks the electronic health record (EHR) system at each site where Dr. Vega-Cordova practices. Vendor and product names are available with a free account.

Otolaryngology is Dr. Vega-Cordova's primary specialty in the NPI Registry, under taxonomy code 207Y00000X. Dr. Vega-Cordova is board certified in otolaryngology by the American Board of Otolaryngology - Head and Neck Surgery. Dmand AI has Dr. Vega-Cordova's licenses on file in 3 states: Florida, Arizona and Illinois.

Dmand AI lists chronic sinusitis, ear eustachian tube disorders, ear infection, endoscopic sinus surgery, hearing loss and impairment, larynx and vocal cord disease, swimmer's ear and tinnitus among the conditions Dr. Vega-Cordova treats.

CMS data shows 250 Medicare services from Dr. Vega-Cordova across 9 procedure codes in 2024, for 76 Medicare patients. Medicare paid $16,260 for them. Every service was in an office.

CMS counts 76 Medicare patients who saw Dr. Vega-Cordova in 2024. The largest group is 65 to 74, with 28 patients. 75% of them have high blood pressure, and 74% have high cholesterol. 74% are also on Medicaid. Their average risk score is 1.55, where 1.00 is the Medicare average, so they are sicker than most Medicare patients.

Across all payers, Dmand AI patient panel data puts Dr. Vega-Cordova's median patient age at 65, with 55% women.

In 2024, Dr. Vega-Cordova wrote 1,213 Medicare Part D claims for 338 patients. 98% of them were for generic drugs. CMS names the drug for 1,139 of them, across 17 drugs with 11 or more claims each, at $25,969 in total drug cost. In 2023, CMS named 1,180 claims across 18 drugs.

CMS publishes a Merit-based Incentive Payment System (MIPS) score of 70 out of 100 for Dr. Vega-Cordova for performance year 2024, reported as part of a group. Dr. Vega-Cordova accepts Medicare assignment, so Medicare's approved amount is taken as full payment.

CMS Open Payments shows 34 general payments to Dr. Vega-Cordova from 9 drug and device companies from 2016 to 2025. Travel and lodging make up the largest share, 54% of the total. Intersect ENT, Inc. paid the most, $2,753.

Dr. Vega-Cordova graduated from Universidad San Francisco de Quito in 2003. Dr. Vega-Cordova is a member of NHS.

Dr. Vega-Cordova is in network with 16 carriers, including Aetna, Excellus BlueCross BlueShield and Blue Cross Blue Shield of Michigan. PPO plans come from the most carriers, 11. Check the plan with the practice before a visit.